InvestigateTV+ shares Poppy and Oliver’s story:
See the story HERE
Category Archives: Alzheimer Overview
Scientists just watched Alzheimer’s damage happen in real time
Scientists at Oregon State University have captured something researchers have long struggled to see: the real-time chemical interactions that help drive Alzheimer’s disease. By watching how metal ions—especially copper—trigger harmful protein clumping in the brain, the team uncovered a clearer picture of how the disease develops at a molecular level.
Read the article HERE
A new type of dementia is forcing doctors to rethink memory loss
Doctors are only just getting to grips with LATE – a newly recognised form of cognitive decline behind up to one in five dementia cases
When a parent or grandparent begins forgetting names, misplacing objects or repeating the same stories, the diagnosis most people expect is Alzheimer’s disease. For decades, Alzheimer’s has dominated public understanding of dementia, becoming almost shorthand for memory loss itself.
But that assumption is increasingly being challenged. Neurologists now know that a significant number of people with Alzheimer’s-like symptoms actually have a different condition altogether – one that most families, and even many doctors, have only recently heard of.
Read more HERE
Exposure to power line EMF radiation linked to higher Alzheimer’s death risk
An 18-year nationwide cohort study of over 3.5 million adults in Switzerland published in Environment International by Nekane Sandoval-Diez et al. found an association between long-term residential exposure to the magnetic field EMF emitted by power lines and an increased risk of death from Alzheimer’s disease and other forms of dementia.
Read more about it HERE
Risk of Alzheimer Dementia After High-Dose vs Standard-Dose Influenza Vaccination
Previous studies, including large cohort analyses comparing vaccinated and unvaccinated adults, suggest that routine immunizations such as inactivated influenza vaccines (IIVs) may reduce Alzheimer dementia (AD) risk. Whether AD risk differs after high-dose IIV (H-IIV) vs standard-dose IIV (S-IIV) remains unexamined. We hypothesized that AD risk would be lower among adults ≥65 years after H-IIV compared with S-IIV.
Read the study HERE
Women get Alzheimer’s more often than men: Five things the science tells us
Women develop Alzheimer’s disease at higher rates than men. Stanford Medicine neurologists explain what science knows about why and the many things it doesn’t yet know.
Read the article HERE